This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.